Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Declaration Capital is the family office of David Rubenstein, the co-founder and co-chairman of The Carlyle Group. The firm operates as a private investment vehicle with a significant focus on venture capital, growth equity, and real estate, particularly within the healthcare and life sciences sectors. Through its affiliated investment platform, Declaration Partners, the firm provides long-term capital to innovative companies that are transforming healthcare delivery, biotechnology, and health technology. Notable healthcare-related investments in its portfolio include Devoted Health, Cityblock Health, and the biomanufacturing platform Resilience. Declaration Capital leverages its deep industry network and flexible mandate to support the growth of companies addressing complex challenges in patient care and medical innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Declaration Capital.